In 2024 alone, approximately 297,790 women and 2,800 men will be diagnosed with breast cancer, and it’s estimated that up to 30 percent of patients will develop metastatic disease.
That’s why Spotlight on Metastatic Breast Cancer takes an in-depth look at the driving forces and innovations behind the latest diagnostic and treatment advances, featuring expert insights from leading clinicians and researchers dedicated to the fight against this disease.
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
Treating Metastatic Breast Cancer: Where Are We Now?
Treating Metastatic Breast Cancer: Where Are We Now?
A Look at the Therapeutic Landscape for Metastatic Breast Cancer
A Look at the Therapeutic Landscape for Metastatic Breast Cancer
